---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-002835"
form_type: "8-K"
ticker: "PCSA"
cik: "0001533743"
company_name: "Processa Pharmaceuticals, Inc."
filed_at: "2024-01-18T23:59:59+00:00"
generated_at: "2026-06-06T21:54:18.636816+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Processa Pharmaceuticals to effect 1-for-20 reverse stock split to regain Nasdaq compliance

## Summary
- Reverse split ratio 1-for-20, effective 12:01 a.m. ET Jan. 22, 2024.
- Outstanding shares reduce from ~24.6M to ~1.2M.
- No fractional shares; rounding up to nearest whole share.
- Intended to regain compliance with Nasdaq $1 minimum bid price.
- Stock continues trading under symbol PCSA with new CUSIP 74275C304.

## SEC filing metadata
- accession: 0001493152-24-002835
- form_type: 8-K
- ticker: PCSA
- cik: 0001533743
- company_name: Processa Pharmaceuticals, Inc.
- filed_at: 2024-01-18T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 3.03, 5.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1533743/000149315224002835/0001493152-24-002835-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1533743/000149315224002835/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-002835
- JSON: https://secwatch.observer/filing/0001493152-24-002835.json
- Plain text: https://secwatch.observer/filing/0001493152-24-002835.txt

## Key facts
- Governance Changes
  Processa Pharmaceuticals, Inc.: Certificate of Amendment to Fourth Amended and Restated Certificate of Incorporation to effect a 1-for-20 reverse stock split (effective 2024-01-22).
  - Change: charter amendment
  - Effective: 2024-01-22
  source text: On January 18, 2024, Processa Pharmaceuticals, Inc. (the “Company”) filed with the Secretary of State of the State of Delaware a Certificate of Amendment (the “Certificate of Amendment”) to the Company’s Fourth Amended and Restated Certificate of Incorporation to effect a 1-for-20 reverse stock split (the “Reverse Stock Split”) of the Company’s issued and outstanding shares of common stock, par value $0.0001 per share (the “Common Stock”), effective as of 12:01 a.m. Eastern Time on January 22, 2024.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1533743/000149315224002835/0001493152-24-002835-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.